[go: up one dir, main page]

DE60202147D1 - Imidazo(1,5-a!pyrimido)5,4-d!benz azepinderivate als gaba-a-rezeptormodulatoren - Google Patents

Imidazo(1,5-a!pyrimido)5,4-d!benz azepinderivate als gaba-a-rezeptormodulatoren

Info

Publication number
DE60202147D1
DE60202147D1 DE60202147T DE60202147T DE60202147D1 DE 60202147 D1 DE60202147 D1 DE 60202147D1 DE 60202147 T DE60202147 T DE 60202147T DE 60202147 T DE60202147 T DE 60202147T DE 60202147 D1 DE60202147 D1 DE 60202147D1
Authority
DE
Germany
Prior art keywords
pyrimido
gaba
imidazo
receptor modulators
azepine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60202147T
Other languages
English (en)
Other versions
DE60202147T2 (de
Inventor
Raffaello Masciadri
William Thomas
Juergen Wichmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HOFFMANN LA ROCHE
F Hoffmann La Roche AG
Original Assignee
HOFFMANN LA ROCHE
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HOFFMANN LA ROCHE, F Hoffmann La Roche AG filed Critical HOFFMANN LA ROCHE
Publication of DE60202147D1 publication Critical patent/DE60202147D1/de
Application granted granted Critical
Publication of DE60202147T2 publication Critical patent/DE60202147T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DE60202147T 2001-05-18 2002-05-08 Imidazo(1,5-a)pyrimido(5,4-d)(1)benzazepinderivate als GABA-A-Rezeptormodulatoren Expired - Lifetime DE60202147T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01112222 2001-05-18
EP01112222 2001-05-18
PCT/EP2002/005121 WO2002094834A1 (en) 2001-05-18 2002-05-08 Imidazo [1,5-a] pyrimido [5,4-d] benzazepine derivatives as gaba a receptor modulators

Publications (2)

Publication Number Publication Date
DE60202147D1 true DE60202147D1 (de) 2005-01-05
DE60202147T2 DE60202147T2 (de) 2005-12-01

Family

ID=8177471

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60202147T Expired - Lifetime DE60202147T2 (de) 2001-05-18 2002-05-08 Imidazo(1,5-a)pyrimido(5,4-d)(1)benzazepinderivate als GABA-A-Rezeptormodulatoren

Country Status (38)

Country Link
US (1) US6686352B2 (de)
EP (1) EP1399448B1 (de)
JP (1) JP4068466B2 (de)
KR (1) KR100533406B1 (de)
CN (1) CN1230436C (de)
AR (1) AR033753A1 (de)
AT (1) ATE283857T1 (de)
AU (1) AU2002338898B2 (de)
BG (1) BG108369A (de)
BR (1) BR0209859A (de)
CA (1) CA2446903C (de)
CZ (1) CZ20033355A3 (de)
DE (1) DE60202147T2 (de)
DK (1) DK1399448T3 (de)
EC (1) ECSP034851A (de)
ES (1) ES2232778T3 (de)
GT (1) GT200200087A (de)
HK (1) HK1066544A1 (de)
HR (1) HRP20030890A2 (de)
HU (1) HUP0400743A3 (de)
IL (2) IL158572A0 (de)
JO (1) JO2297B1 (de)
MA (1) MA27024A1 (de)
MX (1) MXPA03010529A (de)
MY (1) MY127570A (de)
NO (1) NO20035104L (de)
NZ (1) NZ529097A (de)
PA (1) PA8545201A1 (de)
PE (1) PE20030041A1 (de)
PL (1) PL366846A1 (de)
PT (1) PT1399448E (de)
RU (1) RU2287531C2 (de)
SI (1) SI1399448T1 (de)
SK (1) SK15252003A3 (de)
TW (1) TWI251489B (de)
WO (1) WO2002094834A1 (de)
YU (1) YU90003A (de)
ZA (1) ZA200308544B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101748290B1 (ko) 2004-05-14 2017-06-16 밀레니엄 파머슈티컬스 인코퍼레이티드 아우로라 키나아제의 억제에 의해 유사분열 진행을 억제하기 위한 화합물 및 그 방법
CN101068815B (zh) * 2004-10-04 2012-09-05 千禧药品公司 有效作为蛋白激酶抑制剂的内酰胺化合物
KR100915469B1 (ko) * 2004-10-20 2009-09-03 에프. 호프만-라 로슈 아게 할로겐 치환된 벤조다이아제핀 유도체
NZ554439A (en) * 2004-10-20 2009-09-25 Hoffmann La Roche Imidazo-benzodiazepine derivatives
CA2625611A1 (en) * 2005-10-11 2007-04-19 F. Hoffman-La Roche Ag Imidazo benzodiazepine derivatives
PE20080145A1 (es) 2006-03-21 2008-02-11 Janssen Pharmaceutica Nv Tetrahidro-pirimidoazepinas como moduladores de trpv1
CL2007003244A1 (es) 2006-11-16 2008-04-04 Millennium Pharm Inc Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
CL2008003749A1 (es) 2007-12-17 2010-01-15 Janssen Pharmaceutica Nv Compuestos derivados de imidazol, oxazol, y tiazol pirimidina, moduladores de trpv1, proceso de preparacion, composicion farmaceutica y su uso en el tratamiento de enfermedades, trastornos o condicion de dolor, prurito, artritis, tos, asma, trastorno del oido interno y enfermedad inflamatoria intestinal, entre otras.
CN101735211B (zh) * 2008-11-04 2012-11-14 复旦大学 2,3-二氢[1,5]苯并噻氮杂*类化合物或其盐在制备GSK-3β抑制剂中的用途
AR074487A1 (es) 2008-12-05 2011-01-19 Millennium Pharm Inc Tiolactamas inhibidoras de proteinquinasas plk, composiciones farmaceuticas que las contienen y usos de las mismas para el tratamiento de trastornos proliferativos e inflamatorios, en particular cancer.
EP2376082B1 (de) 2008-12-22 2014-03-05 Millennium Pharmaceuticals, Inc. Kombination von aurora-kinase-inhibitoren und anti-cd20-antikörpern
JO3635B1 (ar) 2009-05-18 2020-08-27 Millennium Pharm Inc مركبات صيدلانية صلبة وطرق لانتاجها
WO2011103089A1 (en) 2010-02-19 2011-08-25 Millennium Pharmaceuticals, Inc. Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6--methoxyphenyl)-5h -pyrimido[5,4-d][2]benzazepin-2yl]amino}-2-methoxybenzoate
CN101891706B (zh) * 2010-04-09 2013-05-29 复旦大学 3,4-二氢苯并[f][1,4]噻氮杂*类化合物或其盐及其药物用途
CN102424670A (zh) * 2011-10-31 2012-04-25 江苏阿尔法药业有限公司 一种合成3-(3-氯丙基)-1,3,4,5-四氢-7,8-二甲氧基-2h-3-苯并氮杂卓-2-酮的方法
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
US20130303519A1 (en) 2012-03-20 2013-11-14 Millennium Pharmaceuticals, Inc. Methods of treating cancer using aurora kinase inhibitors
CN105209042B (zh) 2013-03-22 2019-03-08 米伦纽姆医药公司 催化性mtorc 1/2抑制剂与选择性极光a激酶抑制剂的组合
CN106068256B (zh) 2013-12-20 2020-10-23 艾吉因生物股份有限公司 用于治疗认知损害的苯并二氮杂*衍生物、组合物和方法
IL256354B (en) 2015-06-19 2022-09-01 Agenebio Inc Benzodiazepine derivatives, compositions, and uses thereof for treating cognitive impairment
US20180207173A1 (en) 2015-07-21 2018-07-26 Millennium Pharmaceuticals, Inc. Administration of aurora kinase inhibitor and chemotherapeutic agents
US11505555B2 (en) 2016-12-19 2022-11-22 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
MX2020013927A (es) 2018-06-19 2021-03-02 Agenebio Inc Derivados de benzodiazepina, composiciones y metodos para tratar el deterioro cognitivo.
CN110452172B (zh) * 2019-08-21 2021-03-26 爱斯特(成都)生物制药股份有限公司 一种苯并己内酰胺的合成方法
CN112159411A (zh) * 2020-10-15 2021-01-01 南京工业大学 一种三氟甲基取代嘧啶并[1,3]二氮杂*化合物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201311B (de) 1991-06-17 1993-03-01 Hoffmann La Roche
FR2783828B1 (fr) 1998-09-29 2000-11-10 Synthelabo Derives d'acide 5,6-dihydro-4h-imidazo[1,2-a][1] benzazepine -1-acetique, leur preparation et leur application en therapeutique
ES2195943T3 (es) 1999-11-12 2003-12-16 Neurogen Corp Compuestos heteroaromaticos biciclicos y triciclicos.
TWI239333B (en) 2000-11-16 2005-09-11 Hoffmann La Roche Benzodiazepine derivatives as GABA A receptor modulators

Also Published As

Publication number Publication date
SI1399448T1 (en) 2005-02-28
BG108369A (bg) 2005-01-31
PA8545201A1 (es) 2003-02-28
YU90003A (sh) 2006-08-17
JP4068466B2 (ja) 2008-03-26
ZA200308544B (en) 2005-01-31
KR100533406B1 (ko) 2005-12-02
PT1399448E (pt) 2005-03-31
MA27024A1 (fr) 2004-12-20
NO20035104D0 (no) 2003-11-17
AU2002338898B2 (en) 2007-03-15
US20030055042A1 (en) 2003-03-20
CZ20033355A3 (en) 2004-07-14
DK1399448T3 (da) 2005-04-11
GT200200087A (es) 2003-06-19
AR033753A1 (es) 2004-01-07
BR0209859A (pt) 2004-06-15
IL158572A0 (en) 2004-05-12
US6686352B2 (en) 2004-02-03
CA2446903C (en) 2008-12-30
CN1509289A (zh) 2004-06-30
EP1399448A1 (de) 2004-03-24
NO20035104L (no) 2003-11-17
TWI251489B (en) 2006-03-21
IL158572A (en) 2010-02-17
HUP0400743A2 (hu) 2004-07-28
PL366846A1 (en) 2005-02-07
HRP20030890A2 (en) 2005-08-31
AU2002338898B8 (en) 2002-12-03
MXPA03010529A (es) 2004-03-02
NZ529097A (en) 2005-04-29
SK15252003A3 (sk) 2004-08-03
MY127570A (en) 2006-12-29
ATE283857T1 (de) 2004-12-15
ES2232778T3 (es) 2005-06-01
EP1399448B1 (de) 2004-12-01
PE20030041A1 (es) 2003-02-07
CA2446903A1 (en) 2002-11-28
HK1066544A1 (en) 2005-03-24
DE60202147T2 (de) 2005-12-01
JP2004531563A (ja) 2004-10-14
WO2002094834A1 (en) 2002-11-28
KR20040002975A (ko) 2004-01-07
HUP0400743A3 (en) 2007-09-28
RU2003136078A (ru) 2005-05-27
JO2297B1 (en) 2005-09-12
RU2287531C2 (ru) 2006-11-20
CN1230436C (zh) 2005-12-07
ECSP034851A (es) 2003-12-24

Similar Documents

Publication Publication Date Title
DE60202147D1 (de) Imidazo(1,5-a!pyrimido)5,4-d!benz azepinderivate als gaba-a-rezeptormodulatoren
ATE251623T1 (de) Imidazo(1,2-a)pyridin- und pyrazolo(2,3- a)pyridinderivate
ATE284404T1 (de) Pyrazolo(4,3-d)pyrimidinderivate
DK1699795T3 (da) Substituerede 8'-pyri(mi)dinyldihydrospiro[cycloalkylamin]-pyrimido[1,2-a]pyrimidin-6-onderivater
DE60103776D1 (de) Benzodiazepinderivate als gaba-a-rezeptormodulatoren
NO20022738L (no) Pyrrolo(2,3-d)pyrimidinforbindelser
PT996621E (pt) Derivados da triazolo¬4,5-d|pirimidina como agentes anti-tromboticos
IL160878A0 (en) Imidazo (4,3-e)-1,2,4-triazolo (1,5-c) pyrimidines as adenosine a2a receptor antagonists
NO20041142L (no) Subsitituerte 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-on og 7-pyrimidinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)on-derivater for neurodegenerative lidelser
ATE269333T1 (de) 2-pyridinyl-6,7,8,9-tetrahydropyrimido(1,2- a)pyrimidin-4-on- und 7-pyridinyl-2,3- dihydroimidazo(1,2-a)pyrimidin-5 1honderivate
DK1430057T3 (da) Substituerede 2-pyridinyl-6,7,8, 9-tetrahydropyrimido [1,2-a] pyrimidin-4-on- og 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1H)onderivater
EE200100377A (et) Imidaso[1,5-a]-pürido[3,2-e]-pürasinoonide kasutamine arstimitena
DK1210349T3 (da) Pyrazolo[4,3-d]pyrimidiner
EE200400078A (et) Tritsüklilisi 5,6-dihüdro-9H-pürasolo[3,4-c]-1,2,4-triasolo[4,3-alfa]püridiine sisaldavad inhalatsioonikompositsioonid
PL370565A1 (en) 5-methoxy-8-aryl-[1,2,4] triazolo [1,5-a] pyridine derivatives as adenosine receptor antagonists
DK1678182T3 (da) Fremgangsmåde til fremstilling af substituerede 5-amino-pyrazolo[4,3-E]-1,2,4-triazolo-[1,5-C]pyrimidiner
DE69902606D1 (de) Spiro(piperidin-4,1'-pyrrolo(3,4-c)pyrrole)
PT1326866E (pt) 3,4-di-hidropirido[1,2-a]pirimidinas substituidas
ATE294180T1 (de) Substituierte 3,4-dihydro-pyrimido (1,2- a)pyrimidine und 3,4-dihydropyrazino (1,2- a)pyrimidine
EE200100700A (et) Asendatud [1,4]diasepino[6,7,1-hi]indool-4-oonidevalmistamismeetod
DK1330457T3 (da) Cyclopenta[b][1,4]diazepino[6,7,1-hi]indoler som 5HT2C-antagonister
PL366807A1 (en) New derivatives of 1h-pyrazolo[4,3-e]-1,2,4-triazolo[3,4-b][1,2,4]- triazine system
DK1326866T3 (da) Substituerede 3,4-dihydro-pyrido[1,2-a]pyrimidiner

Legal Events

Date Code Title Description
8364 No opposition during term of opposition